Julien Haber¹, Gebrayel Saliba², Elie Haddad², Nabil Chehata² and Jacques Choucair²*

¹Saint Joseph University, Hotel Dieu de France, Urology Department, Lebanon
¹Saint Joseph University, Hotel Dieu de France, Infectious Diseases Department, Lebanon

*Corresponding Author: Jacques Choucair, Saint Joseph University, Hotel Dieu de France, Infectious Diseases Department, Lebanon.

Received: November 26, 2024; Published: January 31, 2025

Abstract

Human papillomavirus (HPV) is a double-stranded DNA virus that exclusively infects humans. There are more than 200 types of HPV, which differ in their tissue tropism and pathogenic potential. Infection occurs through contact of one epithelial surface with another, and manifests itself in different clinical forms, depending on the location of the infection and the type of HPV involved. HPV infection is very common. Between 2013 and 2014, for example, the prevalence of HPV infection in American women aged 18 to 59 was 40% for all HPV types [1]. The particularity of HPV is that some types have oncogenic potential. Indeed, HPV types 16, 18, 31 and 45 are the types most associated with genital cancers [2], including cervical cancer, the fourth most common cancer in women [3]. Thus, a study demonstrated the potential involvement of HPV infection in 90% of cases of cervical cancer [4].

Keywords: Human Papillomavirus (HPV); DNA

References

1. McQuillan G and Unger ER. “Prevalence of HPV in Adults Aged 18-69: United States, 2011-2014”. 280 (2017): 8.
2. Kumar Vinay., et al. “Chapter 19 The Female Genital System and Breast”. Robbins Basic Pathology (8 ed.). Philadelphia: Saunders (2007).
3. Worldwide cancer data. World Cancer Research Fund. (2018).
4. Muñoz N., et al. “Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer”. The New England Journal of Medicine 6 (2003): 518-527.
5. Arbyn M., et al. “Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors”. Cochrane Database System Review 5 (2018): CD009069.
6. Schiffman M., et al. “Carcinogenic human papillomavirus infection”. Nature Reviews Disease Primers 2 (2018): 16086.
7. Abou El-Ola MJ., et al. “Low rate of human papillomavirus vaccination among schoolgirls in Lebanon: barriers to vaccination with a focus on mothers’ knowledge about available vaccines”. Therapeutics and Clinical Risk Management 14 (2018): 617-626.
8. Salameh P., et al. “Attitudes towards and practice of sexuality among university students in lebanon”. Journal of Bio society Science2 (2016): 233-248.
9. Leung SOA., et al. “Educating healthcare providers to increase Human Papillomavirus (HPV) vaccination rates: A Qualitative Systematic Review”. Vaccine X 3 (2019): 100037.
10. Abi Jaoude J., et al. “Factors associated with Human Papilloma Virus (HPV) vaccine recommendation by physicians in Lebanon, a cross-sectional study”. Vaccine49 (2018): 7562-7567.
11. Abi Jaoude J., et al. “Barriers, Attitudes and Clinical Approach of Lebanese Physicians Towards HPV Vaccination; A Cross- Sectional Study”. Asian Pacific Journal of Cancer Prevention 10 (2019): 3181-3187.
12. Swarnapriya K., et al. “Knowledge, Attitude and Practices Regarding HPV Vaccination Among Medical and Para Medical in Students, India a Cross Sectional Study”. Asian Pacific Journal of Cancer Prevention 18 (2016): 8473-8477.
13. Canon C., et al. “Knowledge and Attitudes Towards Human Papillomavirus (HPV) Among Academic and Community Physicians in Mangalore, India”. Journal of Cancer Education2 (2017): 382-391.
14. Steben M., et al. “A National Survey of Canadian Physicians on HPV: Knowledge, Barriers, and Preventive Practices”. Journal of Obstetrics and Gynaecology Canada5 (2019): 599-607.e3.

Citation

Citation: Jacques Choucair., et al. “Knowledge Among Doctors, Residents and Medical Students in Lebanon of the Human Papillomavirus, its Vaccination and Cervical Cancer".Acta Scientific Microbiology 8.2 (2025): 121-128.

Copyright

Copyright: © 2025 Jacques Choucair., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.